Gayle Taylor

Statistics

Publications

Citations

223

H-Index

Active since

2001

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Gayle Taylor is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in enzyme inhibition, drug discovery, and novel antibacterial drug discovery.

Publications per year

2001–2011

Publications

Biphenyl-Substituted Oxazolidinones as Cholesteryl Ester Transfer Protein Inhibitors: Modifications of the Oxazolidinone Ring Leading to the Discovery of Anacetrapib

Cameron J. Smith, Amjad Ali, Milton L. Hammond et al. · Journal of Medicinal Chemistry · 2011 · 70 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

TIGHT BUT LOOSE: SCALING UP TEACHER PROFESSIONAL DEVELOPMENT IN DIVERSE CONTEXTS

E. Caroline Wylie, Laura Goe, Dawn Leusner et al. · ETS Research Report Series · 2008 · 63 citations · Full text

Education, Teacher Education, Teaching +12

Novel Pyrazolo[3,4-<i>d</i>]pyrimidine-Based Inhibitors of <i>Staphlococcus aureus</i> DNA Polymerase III: Design, Synthesis, and Biological Evaluation

Amjad Ali, Gayle Taylor, Ken Ellsworth et al. · Journal of Medicinal Chemistry · 2003 · 62 citations

Pharmacy, Microbiology, Pharmacology +14

Design and synthesis of novel antibacterial agents with inhibitory activity against DNA polymerase III

Amjad Ali, Susan D. Aster, Donald W. Graham et al. · Bioorganic & Medicinal Chemistry Letters · 2001 · 18 citations

Life Sciences, Medicinal Chemistry, Molecular Biology +15

SAR studies on the central phenyl ring of substituted biphenyl oxazolidinone-potent CETP inhibitors

Zhijian Lu, Yiheng Chen, Joann B. Napolitano et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 10 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

1–5 of 5